Valeant Pharmaceuticals International Inc (NYSE:VRX)

Data as of Jan 27
 +0.94 / +0.59%
Today’s Change
Today|||52-Week Range

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year




Revenue and IncomeNet Revenues1.2B2.5B3.5B5.8B
Operating ExpensesGross Income555.7M1.2B1.6B2.6B
Other Operating Expenses0.000.000.00174.2M
Total Operating Expenses970.4M1.9B2.8B4.8B
Non-Operating ExpensesOperating Income210.9M540.6M744.1M948.2M
Extraordinary Credit0.0011.0M5.3M29.3M
Extraordinary Charge-364.7M-290.0M-698.0M-1.4B
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-236.3M-18.0M-394.2M-1.3B
Income Taxes-28.1M-177.6M-278.2M-450.8M
Minority Interest0.000.000.00-2.5M
Net Income-208.2M159.6M-116.0M-866.1M
Shares To Calculate EPSShares To Calculate EPS195.8M304.7M305.4M321.0M
Shares To Calculate EPS Diluted195.8M326.1M305.4M321.0M
Earnings Per ShareEPS-$1.06$0.52-$0.38-$2.70
EPS Diluted----------

Most stock quote data provided by BATS. Market indices are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer.

Morningstar: © 2015 Morningstar, Inc. All Rights Reserved.

Factset: FactSet Research Systems Inc. 2015. All rights reserved.

Chicago Mercantile Association: Certain market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved.

Dow Jones: The Dow Jones branded indices are proprietary to and are calculated, distributed and marketed by DJI Opco, a subsidiary of S&P Dow Jones Indices LLC and have been licensed for use to S&P Opco, LLC and CNN. Standard & Poor's and S&P are registered trademarks of Standard & Poor’s Financial Services LLC and Dow Jones is a registered trademark of Dow Jones Trademark Holdings LLC. All content of the Dow Jones branded indices © S&P Dow Jones Indices LLC 2015 and/or its affiliates.